Skip to main content
. 2011 Apr 20;31(16):5956–5964. doi: 10.1523/JNEUROSCI.5980-10.2011

Table 2.

Trigeminal neuropathic pain subjects characteristics

Subject Age (years) Gender Pain duration (years) Site TNP subcategory Mean pain intensity week before scanning (10 cm VAS) Pain intensity before scan (10 cm VAS) Analgesic medication
174 73 F 35 Right Neuralgia 3.9 4 None
178 51 M 3.5 Right Neuropathy 2.1 5.5 Amitriptyline hydrochloride
179 48 F 9 Bilateral Neuropathy 2.5 2.5 Gabapentin
181 42 F 2 Right Neuropathy 5.5 1.3 Neurontin
182 64 F 11 Right Neuropathy 5 5 Gabapentin
194 52 F 3.5 Right Neuropathy 4.5 0 None
229 47 F 5 Left Neuropathy 1.1 1.9 None
252 67 F 20 Left Neuralgia 2.8 3.0 Baclofen
257 50 M 6 Left Neuralgia 2.3 0 Pregabalin
260 60 F 6 Bilateral Neuralgia 3.2 2.4 Celecoxib, paracetamol
261 53 F 2.5 Right Neuropathy 1.5 1.1 None
262 52 F 1.5 Bilateral Neuropathy 6.9 6.1 Gabapentin, oxycodone, and paracetamol
264 55 F 2 Left Neuropathy 5.2 6.7 Amitriptyline hydrochloride, gabapentin, oxycodone hydrochloride, and paracetamol
265 75 F 35 Right Neuralgia 0.5 0.3 Gabapentin and carbamazepine
266 46 M 9 Bilateral Neuropathy 3.1 1.8 None
269 62 F 7 Right Neuralgia 4.8 6.3 None
276 46 F 3 Bilateral Neuropathy 6.5 5.2 Diazepam, paracetamol, and ibuprofin (PRN)
280 42 F 11 Bilateral Neuropathy 4.8 4.0 Carbamazepine and paracetamol
291 56 M 2 Left Neuralgia 0.9 0.4 Carbamazepine
340 48 F 1.3 Bilateral Neuropathy 2.6 3.2 Gabapentin
341 61 F 2.5 Right Neuralgia 3.1 2.8 None
Mean ± SEM 55 ± 2.1 8.5 ± 2.1 3.5 ± 0.4 3.4 ± 0.5

All trigeminal neuralgia patients and trigeminal neuropathy patients fulfilled the criteria for trigeminal neuropathic pain according to the Liverpool criteria (Nurmikko and Eldridge, 2001). PRN, Pro re nata (“as needed”); F, female; M, male.